These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34418162)

  • 21. The effect of interactions between proteinuria, activity of fibroblast growth factor 23 and serum phosphate on renal progression in patients with chronic kidney disease: a result from the KoreaN cohort study for Outcome in patients With Chronic Kidney Disease study.
    Kim H; Park J; Nam KH; Jhee JH; Yun HR; Park JT; Han SH; Chung W; Oh KH; Park SK; Kim SW; Kang SW; Choi KH; Ahn C; Yoo TH
    Nephrol Dial Transplant; 2020 Mar; 35(3):438-446. PubMed ID: 30615179
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in FGF-23, Neutrophil/Platelet Activation Markers, and Angiogenin in Advanced Chronic Kidney Disease and Their Effect on Arterial Stiffness.
    Choi HM; Kwon YE; Kim S; Oh DJ
    Kidney Blood Press Res; 2019; 44(5):1166-1178. PubMed ID: 31553973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.
    Gutierrez O; Isakova T; Rhee E; Shah A; Holmes J; Collerone G; Jüppner H; Wolf M
    J Am Soc Nephrol; 2005 Jul; 16(7):2205-15. PubMed ID: 15917335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast growth factor 23 in feline chronic kidney disease.
    Geddes RF; Finch NC; Elliott J; Syme HM
    J Vet Intern Med; 2013; 27(2):234-41. PubMed ID: 23398216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between serum fibroblast growth factor-23 concentrations and blood calcium levels in chronic kidney disease cats with upper urolithiasis.
    Miyakawa H; Hsu HH; Ogawa M; Akabane R; Miyagawa Y; Takemura N
    J Feline Med Surg; 2022 Dec; 24(12):1245-1252. PubMed ID: 35133180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serial Fibroblast Growth Factor 23 Measurements and Risk of Requirement for Kidney Replacement Therapy: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Mehta R; Cai X; Lee J; Xie D; Wang X; Scialla J; Anderson AH; Taliercio J; Dobre M; Chen J; Fischer M; Leonard M; Lash J; Hsu CY; de Boer IH; Feldman HI; Wolf M; Isakova T;
    Am J Kidney Dis; 2020 Jun; 75(6):908-918. PubMed ID: 31864822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers.
    Larsson T; Nisbeth U; Ljunggren O; Jüppner H; Jonsson KB
    Kidney Int; 2003 Dec; 64(6):2272-9. PubMed ID: 14633152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fibroblast growth factor-23 and Alpha-Klotho concentrations in dogs with canine Leishmaniasis.
    Gultekin G; Ulutas PA
    Res Vet Sci; 2024 May; 171():105234. PubMed ID: 38547738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The challenge of controlling phosphorus in chronic kidney disease.
    Cannata-Andía JB; Martin KJ
    Nephrol Dial Transplant; 2016 Apr; 31(4):541-7. PubMed ID: 25770169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial.
    Sigrist M; Tang M; Beaulieu M; Espino-Hernandez G; Er L; Djurdjev O; Levin A
    Nephrol Dial Transplant; 2013 Jan; 28(1):161-9. PubMed ID: 23024219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
    Martin KJ; González EA
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Concentrations of Symmetric Dimethylarginine and Creatinine in Dogs with Naturally Occurring Chronic Kidney Disease.
    Hall JA; Yerramilli M; Obare E; Yerramilli M; Almes K; Jewell DE
    J Vet Intern Med; 2016 May; 30(3):794-802. PubMed ID: 27103204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fibroblast Growth Factor-23 and Carotid Artery Intima Media Thickness in Chronic Kidney Disease.
    Yilmaz G; Ustundag S; Temizoz O; Sut N; Demir M; Ermis V; Sevinc C; Ustundag A
    Clin Lab; 2015; 61(8):1061-70. PubMed ID: 26427152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
    Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic background influences cardiac phenotype in murine chronic kidney disease.
    Neuburg S; Dussold C; Gerber C; Wang X; Francis C; Qi L; David V; Wolf M; Martin A
    Nephrol Dial Transplant; 2018 Jul; 33(7):1129-1137. PubMed ID: 29309658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum uromodulin in dogs with chronic kidney disease.
    Seo D; Yang Y; Hwang SH; Jung JH; Cho S; Choi G; Kim Y
    J Vet Intern Med; 2022 Nov; 36(6):2071-2078. PubMed ID: 36330885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
    Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
    Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hyperphosphatemia in Chronic Kidney Disease (CKD)].
    Wang J; Zhang XY; Guan YF
    Sheng Li Ke Xue Jin Zhan; 2015 Aug; 46(4):241-4. PubMed ID: 26669072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.
    Diniz H; Frazão JM
    Nefrologia; 2013 Nov; 33(6):835-44. PubMed ID: 24158124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.